Articles by Eric Langer

Participate in this year’s 9th Annual Report! Be part of the bio-industry’s most authoritative, comprehensive analysis! Participants contribute to industry benchmarking, are first to receive a summary, and more! Click Here to take part Biopharmaceutical companies have weathered a rough recession, layoffs, and budget trimmings. These cutbacks have affected their vendors as well. In...Full Article »

BioPlan Associates’ 8th Annual Report and Survey of Biopharmaceutical Manufacturing , 2011, identifies the growing need for standards to support rapidly emerging and evolving single use, disposable technologies.  Standards, or the lack thereof, are inhibiting expanded use of SUS devices.  For example, this year’s survey of “Factors That May Restrict Use of...Full Article »

CMOs are providing more advanced outsourcing services to remain competitive, as economic pressures drive demands for greater productivity.  In our current study, the  8th Annual Report and Survey of Biopharmaceutical Manufacturing [ 1 ] we found this year that, while fill/finish activities continue to lead the list, upstream and downstream production take the next top slots, with both...Full Article »

Single use technologies are strong change agents in biopharma manufacturing.  Disposable devices emerge once again as a top new technology of interest among the 352 surveyed biomanufacturers in BioPlan Associates, Inc.’s 2011 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 1 .  This year, respondents indicated which single use systems (SUS)...Full Article »

Budgets for the biomanufacturing sector of biotech show a significant upswing from recent years’ freezes and cuts.  In fact, respondents to BioPlan’s 8 th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production [ 1 ] projected only increases in 2011.  This budget bump reverses the previous 2 years’ slashes.  While a single year does...Full Article »

During the past six years, single use systems and devices have emerged as a key change agent in the biomanufacturing landscape. Acceptance in R&D and scale-up has been driven by their effectiveness in reducing risks of contamination, faster changeovers, advantages over fixed stainless steel systems in cleaning and validation, and significantly reduced time, and costs to get a new...Full Article »